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Abstract. The fgr protooncogene is a member of the 
src family of protein tyrosine kinases.  Recent studies 
have shown that normal myelomonocytic cells and tis- 
sue macrophages are the major sites offgr mRNA ex- 
pression.  In the present study, we have identified the 
fgr protooncogene protein product in HL60 cells and 
have examined its expression as a  function of HL60 
cell maturation.  Whether induced toward monocytic or 
granulocytic lineages, p55  c-~" accumulated in HL60 
cells during maturation.  In differentiated cells, the pro- 
tein was active as a protein tyrosine kinase and was 
localized to peripheral cell membranes.  Demonstration 
that a myristyl group was covalently bound to the pro- 
tein probably accounted for its subcellular distribution. 
These findings establish developmental regulation of 
p55c-~  r in a lineage that represents its natural  site of 
expression. 
N 
'EARLY half of the retrovirus  oncogenes described to 
date either encode protein tyrosine kinases or share 
structural  homology with genes specifying such en- 
zymes. Discoveries identifying  a small number of these on- 
cogenic tyrosine kinases as altered versions of growth factor 
receptors provided impetus for the idea that dysregulation  of 
pathways  normally controlled by growth  factors-such as 
platelet-derived  growth factor (10, 33),  colony-stimulating 
factor 1 (28), and epidermal growth factor (ll)-can be im- 
portant steps in the oncogenic process. It would appear, how- 
ever, that not all oncogenic protein tyrosine kinases represent 
transmembrane  growth factor receptors.  Tyrosine  kinases 
specified by the src protooncogene (31) as well as the closely 
related products of cellularfgr (c-fgr) ~  (15, 17) and yes (30) 
genes do not possess hydrophobic  domains able to span the 
plasma membrane and therefore lack extracellular  ligand- 
binding  domains. 
Although  the src family of oncogenic proteins  exhibits 
known enzymatic and transforming activities (for a recent re- 
view see 16), functions for their normal cellular counterparts 
have been elusive.  The ubiquitous expression of cellular src 
(c-src) has implied the importance of this protooneogene for 
a variety of  cell types but has provided little information con- 
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ceming its possible function.  In contrast, expression offgr 
protooncogene mRNA is limited  in humans  to normal cir- 
culating  granulocytes,  monocytes, and tissue macrophages 
(19). Thus, restricted c-fgr expression  suggests that its func- 
tion  must represent a  feature  common to those cell types 
comprising the myelomonocytic lineage.  Previous findings 
have shown that fgr mRNA accumulates during  differentia- 
tion ofa monocytic cell line (19). In the present study, using 
HL60 cells as a model for myelomonocytic cell maturation, 
we have  detected p55  c-f~" in maturing cells  and  have  ob- 
served its accumulation  during the HL60 differentiation pro- 
cess.  Our  findings  establish  developmental  regulation  of 
p55  "-~r in  a  lineage  that  represents  its  natural  site  of ex- 
pression. 
Materials and Methods 
Cells 
HL60 cells (6) were maintained in RPMI 1640 medium containing 10% 
FBS. For differentiation experiments,  exponentially growing cells were sub- 
cultured  at  a density  of  2.5 x IO  s  cells/ml,  and inducers  were added to  the 
medium  at the following concentrations: I0  -6 M  retinoic  acid (Sigma 
Chemical Co.,  St. Louis,  MO) (1),  1.25% DMSO  (Sigma Chemical Co.) 
(7),  and  20  nM 12-O-tetradecanoyl-phorbol-13-acetate  (TPA; Sigma Chem- 
ical  Co.) (24).  After  induction,  cells  were washed twice with PBS before 
use. NIH 3"I"3  ceils  expressing  chicken p60  c-src  (27)  or p21  ~  (29) have 
been described. Mononuclear cells  isolated  from normal human donors 
were also used. 
RNA Preparation and Analysis 
RNA was purified  from cellular extracts  prepared by homogenization in 
guanidinium thiocyanate as described (5). A genomic fragment from the hu- 
man c-fgr gene (32),  encompassing exon 2 and portions of introns 1 and 
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plementary to the primary c-fgr transcript was synthesized.  Conditions for 
nucleic acid hybridization and St nuclease protection analysis  have been 
previously  reported (19). 
Immunoprecipitation and Kinase Assays 
Around 107 cells were labeled for the last 3 h of their scheduled exposure 
to inducer in 4 ml of (a) methionine-free RPMI 1640 containing 100 ttCi 
[35S]methionine/ml (1,200 Ci/mmol); (b) RPMI 1640 containing 500 ttCi 
[3HlPaimitic acid (23 Ci/mmol); or (c) RPMI 1640 containing [3H]myris- 
tic acid (13 Ci/mmol). Radiolabeled cells were disrupted with 1 ml of lysing 
buffer (10 mM sodium phosphate, pH 7.5, 100 rnM NaCl, 1% Triton X-100, 
0.5 % sodium deoxycholate,  1% Trasylol,  and 1 mM PMSF) per petri dish, 
clarified at 100,000 g for 30 rain, and divided into five equal portions. Sam- 
pies were incubated with antisera for 60 rain at 40C. Antibodies against pep- 
tides that represent amino- and carboxy-terminai regions of the putative pro- 
tein (anti-fgr N and anti-fgr C, respectively)  (19), mAb 327 (20), and mAb 
259 (12) have been described previously.  Immunoprecipitates  were recov- 
ered with the aid of Staphylococcus  aureus protein A bound to Sepharose 
beads (Pharmacia Fine Chemicals, Piscataway, N  J) and analyzed by SDS- 
PAGE. Immune complex kinase assays  using acid-treated  rabbit muscle 
enolase (Sigma Chemical Co.) as an exogenous  substrate were performed 
as described (8). 
Immunoblotting 
Cells were disrupted in iysing buffer supplemented with 0.1% SDS. Lysates 
containing 40 #g of protein weie fractionated by SDS°PAGE and transferred 
electrophoretically  to nitrocellulose filters. Immunodetection using peptide 
antibodies was performed as previously described (18). Briefly, filters were 
incubated for 2 h at room temperature with antibody,  washed,  and treated 
with  t25I-iabeled protein A  (Amersham Corp.,  Arlington Heights,  IL). 
Protein size was estimated by comparison with t4C-labeled protein molec- 
ular mass standards (Bethesda Research Laboratories, Gaithersburg, MD). 
Autoradiography  was performed with the aid of an intensifying  screen at 
-80°C. 
Cell Fractionation 
A modification of the procedure of Lutton et al. (21) was used. Briefly, meta- 
bolically labeled cells were incubated for 30 min at 4°C in hypotonic buffer 
containing 1 mM Tris, pH 7.5, I mM PMSF, and 1% Trasylol. Swollen cells 
were disrupted by 30 strokes in a tight-fitting Dounce homogenizer (Kontes 
Glass Co., Vineland, NJ) un~'l >95% of the nuclei were released as judged 
by phase microscopy. Postnuclear  supernatants were separated into soluble 
and particulate  fractions by centrifugation at 100,000 g for 60 rain at 4"C. 
The soluble fraction was lyophilized,  and each fraction was resuspended in 
an equal volume of lysing buffer for analysis  by immunoprecipitation. 
Immunofluorescent Staining 
Cells were collected by centrifugation  onto gelatin-coated  glass slides, fixed 
with 3 % paraforrnaldehyde,  and permeabilized in the presence of PBS con- 
taining 0.5 mM CaCI2, 0.5 mM MgCI2, and 0.1% Triton X-100. Cells were 
washed and incubated for 45 rain with anti-fgr C serum in the presence or 
absence of  10 /~g fgr C  peptide/ml.  After incubation with fluorescein- 
conjugated  goat anti-rabbit IgG for 45 rain,  staining was  visualized  by 
fluorescent  microscopy. 
Results 
Induction of  fgr Protooncogene  mRNA in HL60 Cells 
Previous studies have shown that normal sources offgr pro- 
tooncogene mRNA are limited to peripheral blood granulo- 
cytes, monocytes, and alveolar macrophages.  Furthermore, 
fgr mRNA levels were shown to increase upon induction of 
monocytic differentiation by the phorbol ester TPA in U937 
cells  (19).  To  determine  whether  c-J~r  expression  also 
responded to myelocytic differentiation,  we assayed for the 
c-fgr transcript in HL60 ceils induced to differentiate toward 
the myelocytic state with retinoic acid.  Maturation  was as- 
sessed by the nitroblue tetrazolium reduction assay (2). At 
1, 2,  3, and 4  d of retinoic acid exposure, 31, 67,  84, and 
96 %, respectively, of treated HL60 cells reduced nitroblue 
tetrazolium as judged by the formation of intracellular  for- 
mazan  precipitates.  Only  1-2 % of untreated  cells demon- 
strated this property. When cultures were examined for ex- 
pression of c-fgr mRNA,  no c-fgr mRNA expression was 
detected in RNA prepared for HL60 cells before treatment 
(Fig.  1). In contrast, mature c-fgr transcript,  represented by 
a band of 239 nucleotides,  increased in abundance during 
retinoic  acid  exposure.  Maximum  levels  of c-fgr mRNA 
were  achieved  at  3-4  d,  the  time  at  which  myelocytic 
differentiation was nearly complete (Fig.  1). Thus, fgr pro- 
tooncogene mRNA accumulates during maturation of HL60 
cells induced to differentiate toward the granulocytic lineage. 
In addition to the 239-nucleotide band representing c-fgr 
exon 2  sequences (19),  bands of 278 and 622 nucleotides 
were protected by RNA from control mononuclear cells as 
well as from treated HL60 cells (Fig.  I). Based upon the in- 
tron-exon composition of the probe used, we concluded that 
precursor RNA molecules containing exon 2 plus intron  1 
gave rise to the 622-nucleotide band. Similarly, exon 2 and 
only intron 2  sequences protected the 278-nucleotide band 
from digestion. Thus, c-fgr RNAs containing introns  1 and 
2 are detectable in maturing HL60 and normal mononuclear 
cells.  These  findings  are  consistent  with  previous studies 
demonstrating  introns 2, 4,  and 7 within  10-20%  of c-fgr 
cDNAs cloned from mononuclear cell mRNA templates (17) 
and the presence of intron 7 in 20% of thefgr transcripts de- 
tected in TPA-treated U937 cells (19). 
Accumulation of  p3J~, during the Course of  ilL60 
Cell Differentiation 
The  primary  structure  of the fgr protooncogene  product 
predicted from nucleotide sequence analysis of c-fgr eDNA 
has recently been reported (15,  17). By using anti-fgr N or 
anti-fgr C, it has been possible to identify p55  ~-~' as the pri- 
mary translational product of the c-fgr gene (17). These same 
antibodies were used in immunoblotting  assays to attempt 
detection of p55 ~-~r in HL60 cells exposed to retinoic acid. 
As shown in Fig. 2, both anti-fgr N and anti-fgr C detected 
a  protein of 55 kD in lysates of treated but not untreated 
HL60 cells. The identity of this protein as p55,-~, was fur- 
ther demonstrated by lack of its detection with either anti- 
body in the presence of homologous peptide (Fig. 2). In ad- 
dition to p55  ¢~r, hands  with molecular masses of <55 kD 
were specifically detected with anti-fgr C but not anti-fgr N 
sera.  These bands may represent p55~-~" proteins that have 
lost portions of their amino-terminal  regions or may repre- 
sent related proteins. In any case, when examined over a 3-d 
time  course,  p55  c~-~r accumulated  at  a  steady  state  in  re- 
sponse to retinoic acid treatment, reaching the highest levels 
at 3 d of induction.  Thus,  p55  "-~r expression parallels that 
of its mRNA in retinoic acid-treated HL60 cells. 
Induction of  p55~-~  , by a Variety  of  Differentiating Agents 
To investigate the ability of monocytic- as well as myelocytic- 
inducing  agents  to  affect  p55  ~-~" expression,  HL60  cells 
were treated with DMSO, which induces myelocytic differ- 
entiation,  or the phorbol ester, TPA, which induces mono- 
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tiation of HL60 cells. RNA was harvested from HL60 
cells before (lane 3) or after treatment  with retinoic 
acid for 6 or 12 h (lanes 4 and 6, respectively) or 1, 
2, 3, or 4 d (lanes 7-10, respectively).  Samples were 
used  to  hybridize  radiolabeled  c-fgr probe  as  de- 
scribed  in Materials  and Methods.  Control  samples 
consisted of probe alone (lane 1) or probe plus tRNA 
(lane 2) or RNA  from normal human m0nonuclear 
cells (lane 5). Sizes of molecules surviving S~ nuclease 
treatment are indicated on the fight in nucleotides. M, 
molecular size standards.  (B) Schematic representa- 
tion of probe used to detect c-fgr mRNA. Closed box 
indicates location of c-fgr exon 2 within labeled DNA 
fragment. Sizes of  probe molecules that would be pro- 
tected by various forms of c-fgr RNA are shown in 
nucleotides.  /VS, intron. 
cytic differentiation. As determined by nitroblue tetrazolium 
reduction assays for DMSO or by morphologic criteria (2) 
for TPA, exposed cultures followed a maturation time course 
nearly identical to that observed with retinoic acid (see above). 
Thus, after 4 d of exposure, 91, 83, or 81%, respectively, of 
cells treated with retinoic acid, DMSO,  or TPA were fully 
differentiated  and  viable.  Lysates of treated cultures  were 
evaluated for p55  c-*r expression by immunoblotting. As shown 
in  Fig.  3,  levels of p55 c'-~r increased during  differentiation 
induced by each of these agents. However, maximum induc- 
tion by DMSO or TPA was •40%  of the p55  c-~r abundance 
observed in retinoic acid-treated cells. These findings dem- 
onstrated that thefgr protooncogene product accumulated in 
HL60 cells that were induced to differentiate toward either 
monocytic or myelocytic lineages. 
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various differentiation agents. HL60 cell extracts were prepared at 
varying times after treatment with inducing agents. Cells seeded at 
a concentration  of 2.5  x  105/ml on day 0 were incubated in the 
presence of retinoic acid,  DMSO, or TPA (A-C, respectively) for 
up to 4 d. Samples were analyzed by immunoblotting using anti-fgr 
C  serum as described  in Materials  and Methods.  Immune com- 
plexes were labeled using iodinated protein A and visualized by au- 
toradiography. The location of p55  ~-~ is indicated. 
Figure 2. Expression of p55  c-J~r during HL60 differentiation. Pro- 
tein extracts were prepared from HL60 cells before (lanes I) or af- 
ter treatment with retinoic acid for 6 or 12 h (lanes 2 and 3, respec- 
tively) or 1, 2,  3, or 4 d (lanes 4-7, respectively).  Samples were 
fractionated by SDS-PAGE and transferred to nitrocellulose filters. 
Filters were incubated with anti-fgr C (A and B) or anti-fgr N (C 
and D). In some cases, antibodies were preincubated with homolo- 
gous peptide (B and D). Immune complexes were labeled using io- 
dinated protein A and visualized by autoradiography. The location 
of p55  "-~r is indicated. 
p55  c~" Is Active as a Protein 1)~osine Kinase 
Genes of the src protooncogene family encode enzymes with 
protein tyrosine kinase activity (for review see 14). To exam- 
ine whether p55~-~  r also possessed this enzymatic activity, 
lysates of HL60 cells treated with retinoic acid were tested 
in  immune  complex  kinase  assays.  As  shown  in  Fig.  4, 
p55  c-ar was autophosphorylated in the assay, and phosphate 
was transferred to enolase, an exogenous substrate that was 
included in the reaction mixture. In contrast, antibody prein- 
cubated withfgr C peptide did not precipitate kinase activity. 
By  phosphoamino  acid  analysis  of labeled  p55c-a  ',  only 
phosphotyrosine was detected, establishing p55  "-~" as a pro- 
tein tyrosine kinase (data not shown). When examined as a 
function of HL60 cell differentiation,  the abundance offgr 
kinase increased with time of exposure to retinoic acid (Fig. 
4).  Thus, p55c-~  " accumulates as an active protein tyrosine 
kinase during the maturation of HL60 cells. 
Localization of  p55~  r in Induced HL60 Cells 
In an effort to define possible cellular locations where the 
tyrosine kinase activity of p55  c-~" might be exerted, we frac- 
tionated retinoic acid-induced HL60 cells into cytosol and 
particulate membrane compartments and assayed each for the 
presence of the fgr protooncogene product by immunopre- 
cipitation.  As  shown in  Fig.  5,  no p55  c-~r was detected  in 
the cytosolic fraction, but the protein was abundant in crude 
membranes. By comparison of signal intensities observed in 
cytosolic and membrane fractions, we concluded that at least 
95 % of p55  c-fgr was membrane associated. 
To confirm the localization of p55  c-~r and to visualize its 
distribution among cellular membranes, we attempted to de- 
tect the protein using an indirect immunofluorescence stain- 
ing approach. As shown in Fig. 6,  staining was readily ob- 
served in HL60 ceils fixed after 2 d of retinoic acid exposure 
but not in uninduced cells. The specificity of the signal was 
further demonstrated when identically prepared cells were 
treated with anti-fgr C  in the presence of homologous pep- 
tide (Fig.  6 B).  As shown in Fig.  6  C, bright fluorescence 
appeared toward the cell periphery with diffuse staining of 
the cytoplasm. Little if any perinuclear or nuclear signal was 
observed. The pattern of staining was consistent with the 1o- 
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kinase  accumulates in  maturing 
HL60 cells. Protein extracts were 
prepared from HL60 cells before 
(lanes I and 2) or after treatment 
with retinoic acid for 6 (lanes 3 
and 4) or 12 h (lanes 5 and 6) or 
2 (lanes 7 and 8), 3 (lanes 9 and 
10), or4 d (lanes//and 12). Sam- 
pies  were  immunopreeipitated 
with anti-fgr C  serum,  and im- 
mune complexes were assayed for 
kinase  activity  as  described  in 
Materials and Methods. In some 
cases,  anti-fgr C  was  preincu- 
bated withfgr C peptide (lanes 2, 
4, 6, 8, 10, and 12). Locations of 
labeled  p55  ~-,~' and  enolase  are 
indicated. 
calization of p55  c-~r to  the  plasma  membrane.  Taken  to- 
gether,  our  findings  revealed  that  the fgr  protooncogene 
product is distributed toward the periphery of mature HL60 
cells in association with membrane components. 
Figure 5. Localization of p55  ~--~ by cell fractionation. HL60 cells, 
treated with retinoic acid for 48 h and metabolically labeled with 
[35S]methionine, were fractionated into soluble 0anes  3 and 4) 
and  particulate  (lanes  5  and  6)  components  as  described  in 
Materials  and Methods. Fractions  as well as whole-cell lysates 
(lanes I and 2) were adjusted in volume such that each represented 
the same number of ceils and were analyzed by immunoprecipita- 
tion using anti-fgr C serum.  In some cases antibody was prein- 
cubated with ~r C peptide (lanes 2, 4, and 6). Location of p55  ¢--~r 
is indicated. 
Modification of  p55~ by Posttranslational Addition of 
Fatty Acid 
The posttranslational addition of a  myristyl group to cyto- 
plasmic p60  `-'r~ has been shown essential for its accumula- 
tion at the inner surface of the plasma membrane (9, 23). To 
determine  whether  similar  modifications  affected  p55  c=~r 
and thereby contributed to its subcellular location, we at- 
tempted to label the c-fgr translational product by incubation 
of induced HL60 cells with tritiated fatty acids. By immuno- 
precipitation with anti-fgr C, p55  ~-~r was detected in lysates 
of myristic acid-labeled cells but was  barely observed in 
cells exposed to [3H]palmitic acid (Fig. 7). Control experi- 
ments showed, as expected, that p60  '-s'~ (3) was more readily 
detectable in lysates of myristic acid-labeled cells, whereas 
the intensity of the p21 '~ (26) band was greater when cells 
were labeled with palmitic acid. These findings demonstrate 
that p55  ¢'-~r is modified by the posttranslational addition of 
fatty acid,  most likely a  myristyl group,  and  suggest that 
p55  "-~ associates with membrane components by virtue of 
this modification. 
Discussion 
The present study has examined expression of the fgr pro- 
tooncogene product, p55c-~  r in maturing  HL60 cells.  The 
choice of this model was based upon previous studies show- 
ing the presence offgr mRNA only in granulocytes, mono- 
cytes, and macrophages (19). Demonstration that p55c-~  r ac- 
cumulated during maturation of HLt0 cells has established 
that expression of thefgr-encoded protein is developmentally 
regulated in HL60 cells. These findings are consistent with 
previous studies that have shown increasingfgr mRNA abun- 
dance during maturation of U937 cells (19). More rapid in- 
duction of c-fgr mRNA during U937 cell maturation as com- 
pared with that of p55  c-~r in HL60 cells probably reflects 
the  relatively advanced state of U93"/ cell differentiation. 
Furthermore, the time course of p55  °-~r induction in HL60 
cells in response to TPA is nearly identical to that previously 
described for p60  ~-s'~ (13).  Abundant c-fgr mRNA is present 
in fully mature human (19) and murine (34) monocytes, and 
p55  c-~r is  expressed at high levels in normal granulocytes 
purified from human blood (13a).  Taken together, the evi- 
Notario et al. Developmental  Regulation of  p55  c'fgr Expression  3133 Figure 6. Localization of p55  c-n~ by indirect immunofluorescence. 
Untreated HL60 cells (A) or cultures treated with retinoic acid for 
48 h (B and C) were fixed and incubated with anti-fgr C. In one 
case, antibody was preincubated with frg C peptide (B). Immune 
complexes were visualized by staining with fluorescein-conjugated 
goat anti-rabbit IgG. 
dence  strongly  suggests  that  accumulation  of  p55  c--~r in 
HL60  cells  maturing  toward  monocytes or  granulocytes 
reflects its normal pattern of expression. 
The extent of p55c-a  '  induction was greatest when HL60 
cells were exposed to retinoic acid as compared with TPA 
or DMSO. Although preliminary studies using lower-titered 
antibodies did not detect p55  ~-~r in HL60 cells exposed to 
TPA (19), p55 c-at clearly accumulated during differentiation 
by TPA.  Similar low levels of p55  ¢-~" were also observed in 
DMSO-treated cells, suggesting no relationship between the 
extent  of p55  ~-ysr induction  and  maturation  toward  either 
monocytic  or  myelocytic  lineages.  The  time  course  of 
differentiation induced by all of the agents tested, including 
retinoic acid, were nearly identical. Thus, the higher levels 
of p55  ¢-~r observed in retinoic acid-treated cells appear to 
relate specifically to retinoic acid. Preliminary experiments 
addressing this issue have taken advantage of an earlier ob- 
servation that Epstein-Barr virus-infected B cells (Ramos- 
AW), but not uninfected Ramos cells, expressed c-fgr mRNA 
(4).  When exposed to retinoic acid, c-fgr mRNA levels in- 
creased two- to threefold in Ramos-AW cells but remained 
undetectable in Ramos cells (our unpublished observations). 
These data would suggest that retinoic acid not only induces 
c-fgr mRNA as a function of HL60 maturation but also has 
an additional enhancing effect on the fgr locus in cells al- 
ready expressing c-fgr mRNA. 
Several recent studies have documented the involvement of 
protein tyrosine kinases in the program of myelomonocytic 
cell differentiation. Expression of  the colony-stimulating  fac- 
tor 1 receptor is induced when HL60 cells differentiate toward 
monocytes but not granulocytes (25). This receptor is known 
to play an important role in both proliferation and maturation 
of monocytes (22). Furthermore, colony-stimulating  factor 1 
stimulation of  bone marrow-derived monocytic  cells induces 
the expression of c-fgr mRNA (34), a finding consistent with 
the  presence  of c-fgr mRNA in  resting peripheral  blood 
monocytes (19).  Circulating  monocytes also  express  hck 
mRNA, and even higher expression of hck is achieved upon 
activation of these cells (35). The c-src-specified kinase ac- 
cumulates in HL60 cells during differentiation into mono- 
cytic or granulocytic cells (1, 13). All of these findings sug- 
gest that regulation of tyrosine phosphorylation is of critical 
importance for the development of myelomonocytic cells. 
Although we have no direct evidence for anfgr function, 
our present studies in combination with earlier findings de- 
limit the biologic framework in whichfgr must normally act. 
Within the myelomonocytic  lineage, c-fgr may play a role in 
signaling the  cessation  of cell  growth  in preparation  for 
maturation or may be involved in some aspect of the matura- 
tion process itself. Alternatively, in light of its peripheral 
membrane location, p55  c-~" may function in mature cells in 
response to extracellular signals. In this regard, it may be 
useful to consider response functions-such as chemotaxis, 
phagocytosis, and respiratory burst reactions-that are shared 
by mature monocytes, macrophages, and neutrophils. In any 
case, it is now possible to focus upon myelomonocytic cells 
in the later stages of their development in search of a physio- 
logic role for the fgr protooncogene. 
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cated. 
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